Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy

被引:17
作者
Masson-Lecomte, Alexandra [1 ]
Xylinas, Evanguelos [2 ]
Bouquot, Morgane [3 ]
Sibony, Mathilde [4 ]
Allory, Yves [5 ]
Comperat, Eva [6 ]
Zerbib, Marc [2 ]
de la Taille, Alexandre [1 ]
Roupret, Morgan [3 ]
机构
[1] Paris Est Creteil Univ, Henri Mondor Acad Hosp, Dept Urol, Creteil, France
[2] Paris Descartes Univ, Cochin Hosp, APHP, Dept Urol, Paris, France
[3] Univ Paris 06, Pitie Salpetriere Acad Hosp, Acad Urol Unit, Paris, France
[4] Paris Descartes Univ, Cochin Hosp, APHP, Dept Pathol, Paris, France
[5] Paris Est Creteil Univ, Henri Mondor Acad Hosp, Dept Pathol, Creteil, France
[6] Univ Paris 06, Pitie Salpetriere Acad Hosp, Dept Pathol, Paris, France
关键词
Urothelial carcinoma; Bladder neoplasm; Micropapillary variant; Radical cystectomy; Adjuvant chemotherapy; Survival; TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; URINARY-BLADDER; NEOADJUVANT CHEMOTHERAPY; RISK STRATIFICATION; SURVIVAL; REPRODUCIBILITY; RECURRENCE; MANAGEMENT; CISPLATIN;
D O I
10.1007/s00345-014-1387-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To assess the oncological outcomes of radical cystectomy (RC) and adjuvant chemotherapy to treat muscle-invasive bladder cancer (MIBC) with a micropapillary component (MPC), and to compare outcomes with those from pure urothelial carcinoma (PUC). A retrospective review of clinicopathological and follow-up data was performed for all patients treated by RC and adjuvant platinum-based chemotherapy for advanced MIBC in three tertiary reference centers between 1999 and 2012. Uni- and multivariate Cox's regression analyses evaluated the association of the presence of MPC with disease recurrence and cancer-specific mortality. Two hundred and thirty-five (88 %) PUC and 31 (12 %) MPC cases were included. Median age was 65 (39-83) years in the PUC group and 62 (45-80) years in the MPC group. Median survival was 29 months in the MPC versus 31 months in the PUC group. No significant difference was observed between the groups regarding main clinical and pathological characteristics. The median number of treatment cycles administered was 6 (3-8) in the PUC versus 5 (3-8) in the MPC group (p = 0.45). Five-year disease-free recurrence and cancer-specific survival (CSS) rates were 15 and 24 %, respectively, in the MPC versus 42 and 47 %, respectively, in the PUC group (p = 0.007 and 0.058). In multivariate analyses, ASA score, soft tissue surgical margins, and MPC were associated with disease recurrence (p = 0.022, 0.001, and 0.015, respectively). We found no association between MPC and cancer-specific mortality (univariate, p = 0.06). MPC was associated with higher recurrence rates after RC and platinum-based adjuvant chemotherapy than that with pure urothelial tumors.
引用
收藏
页码:1087 / 1093
页数:7
相关论文
共 33 条
[1]  
Alvarado-Cabrero Isabel, 2005, Ann Diagn Pathol, V9, P1, DOI 10.1053/j.anndiagpath.2004.10.001
[2]   Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings [J].
Alvarado-Cabrero, Isabel ;
Alderete-Vazquez, Georgia ;
Quintal-Ramirez, Marissa ;
Patino, Marcia ;
Ruiz, Erika .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (03) :151-157
[3]   MICROPAPILLARY VARIANT OF TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER - HISTOLOGIC PATTERN RESEMBLING OVARIAN PAPILLARY SEROUS CARCINOMA [J].
AMIN, MB ;
RO, JY ;
ELSHARKAWY, T ;
LEE, KM ;
TRONCOSO, P ;
SILVA, EG ;
ORDONEZ, NG ;
AYALA, AG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (12) :1224-1232
[4]   Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine [J].
Bellmunt, J ;
Albanell, J ;
Paz-Ares, L ;
Climent, MA ;
González-Larriba, JL ;
Carles, J ;
de la Cruz, JJ ;
Guillem, V ;
Díaz-Rubio, E ;
Cortés-Funes, H ;
Baselga, J .
CANCER, 2002, 95 (04) :751-757
[5]   Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer [J].
Bochner, Bernard H. ;
Dalbagni, Guido ;
Kattan, Michael W. ;
Fearn, Paul ;
Vora, Kinjal ;
Seo, Hee Song ;
Zoref, Lauren ;
Abol-Enein, Hassan ;
Ghoneim, Mohamed A. ;
Bochner, Bernard H. ;
Dalbagni, Guido ;
Scardino, Peter T. ;
Bajorin, Dean ;
Skinner, Donald G. ;
Stein, John P. ;
Miranda, Gus ;
Gschwend, Juergen E. ;
Volkmer, Bjoern G. ;
Hautmann, Richard E. ;
Chang, Sam ;
Cookson, Michael ;
Smith, Joseph A. ;
Thalman, George ;
Studer, Urs E. ;
Lee, Cheryl T. ;
Montie, James ;
Wood, David ;
Puigvert, Fundacio ;
Palou, Juan ;
Fradet, Yyes ;
LaCombe, Louis ;
Simard, Pierre ;
Schoenberg, Mark P. ;
Lerner, Seth ;
Vazina, Amnon ;
Bassi, PierFrancesco ;
Murai, Masaru ;
Kikuchi, Eiji .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (24) :3967-3972
[6]   Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Lehmann, J ;
Studer, U ;
Torti, FM ;
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martínez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :189-201
[7]   Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases [J].
Comperat, Eva ;
Roupret, Morgan ;
Yaxley, John ;
Reynolds, Jamie ;
Varinot, Justine ;
Ouzaid, Idir ;
Cussenot, Olivier ;
Samaratunga, Hemamali .
PATHOLOGY, 2010, 42 (07) :650-654
[8]  
Fairey AS, 2013, UROL ONCOL, V32, P110
[9]   ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder [J].
Gakis, Georgios ;
Efstathiou, Jason ;
Lerner, Seth P. ;
Cookson, Michael S. ;
Keegan, Kirk A. ;
Guru, Khurshid A. ;
Shipley, William U. ;
Heidenreich, Axel ;
Schoenberg, Mark P. ;
Sagaloswky, Arthur I. ;
Soloway, Mark S. ;
Stenzl, Arnulf .
EUROPEAN UROLOGY, 2013, 63 (01) :45-57
[10]  
Gaya JM, 2010, CAN J UROL, V17, P5370